Journal of Clinical and Aesthetic Dermatology

JUN 2017

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link:

Contents of this Issue


Page 10 of 63

11 11 vol. 10, no. 6 • JUnE 2017 • JCAD journal of clinical and aesthetic dermatology June 2017 • Volume 10 • Number 6 EDITORIAL MESSAGE Welcome to the June 2017 issue of JCAD . We begin this issue with an original research article by Del Rosso et al titled, "The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings from a Web-based Survey." Here, the authors report findings from a cross-sectional, web-based survey among American men and women who self-reported having a physician's diagnosis of rosacea. The authors found that despite the chronic nature of rosacea, survey participants reported only using prescription agents to treat flare-ups and relying on sun protection and other avoidance mechanisms to reduce flare-up frequency. The authors encourage dermatologists to better educate their patients on the long-term nature of rosacea and the need for continued prescribed treatment to maintain long-term control of symptoms. Next, we present a post-hoc analysis by Alexis et al on the efficacy and tolerability of clindamycin 1.2%/ benzoyl peroxide (BP) 3.75% gel in the treatment of moderate-to- severe acne vulgaris in a Hispanic population. The authors report that the clindamycin phosphate 1.2%/BP 3.75% gel was well tolerated and efficacious in the Hispanic population, and that participants using the study gel experienced greater reductions in inflammatory and noninflammatory lesions compared to the control group. Furthermore, the authors report that Hispanic acne subjects were not found to be more susceptible to cutaneous irritation from treatment with the study gel. Following this, in the review article, "Treatment of Actinic Purpura," Ceiley describes a new product (DerMend®, Ferndale Healthcare) specifically developed for treatment and the prevention of actinic purpura, a condition characterized by unsightly ecchymosis and purple patches. The author reviews the product's observed benefits and also provides a brief literature review of actinic purpura. He anecdotally notes that he has observed increased incidence of actinic purpura among the older patients in his dermatology practice. Lastly, we present "Nonablative Fractional Laser Resurfacing in Skin of Color: Evidence-based Review," by Kaushik and Alexis. Here, the authors explore the available literature on nonablative fractional lasers in Fitzpatrick skin photo types (SPTs) IV–VI and report that the available evidence strongly suggests fractional lasers are a favorable treatment option for a variety of dermatological diseases in Fitzpatrick skin phototypes IV to VI. Specifically, the authors report Level 1 evidence for the use of fractional lasers in the treatment of acne, striae, and skin rejuvenation and Level 2 evidence for treatment of acne scars, melasma, and surgical/traumatic scars. The authors conclude that fractional resurfacing is a safe and efficacious treatment option for various dermatological disorders in darker skin types; however, there is a paucity of high-quality studies involving skin types V and VI. We hope you enjoy this issue of JCAD, and as always, we welcome your feedback and submissions. With regards, James Q. Del Rosso, DO, FAOCD Editor-in-Chief, Clinical Dermatology Wm. Philip Werschler, MD, FAAD, FAACS Editor-in-Chief, Aesthetic Dermatology Seemal R. Desai, MD, FAAD Associate Editor J ames Q. Del Rosso, DO, FAOCD E ditor-in-Chief, Clinical Dermatology The Journal of Clinical and Aesthetic D ermatology Wm. Philip Werschler, MD, FAAD, FAACS Editor-in-Chief, Aesthetic Dermatology The Journal of Clinical and Aesthetic Dermatology Seemal R. Desai, MD, FAAD Associate Editor The Journal of Clinical and Aesthetic Dermatology

Articles in this issue

Links on this page

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - JUN 2017